Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,781
Closed -$310K 154
2023
Q4
$310K Sell
2,781
-346
-11% -$47.7K 0.05% 126
2023
Q3
$510K Sell
3,127
-103
-3% -$18.1K 0.1% 94
2023
Q2
$592K Sell
3,230
-849
-21% -$122K 0.11% 99
2023
Q1
$544K Sell
4,079
-206
-5% -$24.2K 0.11% 100
2022
Q4
$533K Sell
4,285
-238
-5% -$16.8K 0.11% 102
2022
Q3
$266K Buy
+4,523
New +$292K 0.06% 133

Other funds holding ACLS

CIM LLC's ACLS Position: Q1 2024 in Review

CIM LLC sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 2,781 shares — an estimated $310K sold.

CIM LLC first reported a position in ACLS in Q3 2022 and held it in 6 quarters. The position peaked at $592K in Q2 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • CIM LLC reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • CIM LLC sold 2,781 Axcelis shares in Q1 2024, an estimated $310K.
  • CIM LLC first reported a position in Axcelis in Q3 2022 and held it in 6 quarters.
  • CIM LLC's Axcelis position peaked at $592K in Q2 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on CIM LLC's 13F filing for Q1 2024, filed 20 May 2024.